Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Chest
|
June 1, 1992
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase
S Gu, J Ducas, J N Patton, et al.
Nouvelle Revue Francaise D'Hematologie
|
May 1, 1970
[A new case of neonatal thrombopenic purpura due to feto-maternal leukoplatelet allo-immunization]
F Streiff, B Genetet, N Neimann, et al.
Chest
|
May 1, 1986
Hemodynamic management in clinical acute hypoxemic respiratory failure. Dopamine vs dobutamine
D W Molloy, J Ducas, K Dobson, et al.
Chest
|
July 1, 1991
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration
S A Gu, J Ducas, K Wolfe, et al.
Chest
|
March 1, 1991
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism
R M Prewitt, A M Downes, S A Gu, et al.
Circulation
|
July 1, 1988
Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes
F Shiffman, J Ducas, P Hollett, et al.
Archives Francaises De Pediatrie
|
June 1, 1982
[Adolescent medicine in private practice ]
J P Deschamps, A Sturel-Lartigue, J Ducas, et al.
The Canadian Journal of Cardiology
|
November 1, 1995
Walking program reduces elevated cholesterol in women postmenopause
A E Ready, D T Drinkwater, J Ducas, et al.
The Canadian Journal of Cardiology
|
January 1, 1995
Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration
P J Garber, A L Mathieson, J Ducas, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1991
Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis
R M Prewitt, S A Gu, D Greenberg, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Chest
|
June 1, 1992
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase
S Gu, J Ducas, J N Patton, et al.
Nouvelle Revue Francaise D'Hematologie
|
May 1, 1970
[A new case of neonatal thrombopenic purpura due to feto-maternal leukoplatelet allo-immunization]
F Streiff, B Genetet, N Neimann, et al.
Chest
|
May 1, 1986
Hemodynamic management in clinical acute hypoxemic respiratory failure. Dopamine vs dobutamine
D W Molloy, J Ducas, K Dobson, et al.
Chest
|
July 1, 1991
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration
S A Gu, J Ducas, K Wolfe, et al.
Chest
|
March 1, 1991
Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism
R M Prewitt, A M Downes, S A Gu, et al.
Circulation
|
July 1, 1988
Treatment of canine embolic pulmonary hypertension with recombinant tissue plasminogen activator. Efficacy of dosing regimes
F Shiffman, J Ducas, P Hollett, et al.
Archives Francaises De Pediatrie
|
June 1, 1982
[Adolescent medicine in private practice ]
J P Deschamps, A Sturel-Lartigue, J Ducas, et al.
The Canadian Journal of Cardiology
|
November 1, 1995
Walking program reduces elevated cholesterol in women postmenopause
A E Ready, D T Drinkwater, J Ducas, et al.
The Canadian Journal of Cardiology
|
January 1, 1995
Thrombolytic therapy in cardiogenic shock: effect of increased aortic pressure and rapid tPA administration
P J Garber, A L Mathieson, J Ducas, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
October 1, 1991
Effects of flow on recombinant tissue plasminogen activator-induced pulmonary thrombolysis
R M Prewitt, S A Gu, D Greenberg, et al.
Page
of 5